Peptide Antibiotics Market to grow with a CAGR of 6.79% through 2030
Increasing healthcare infrastructure and a supportive regulatory environment is expected to drive the Global Peptide Antibiotics Market growth in the forecast period, 2026-2030.
According
to TechSci Research report, “Peptide Antibiotics Market - Global Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2030”, Global Peptide Antibiotics
Market has valued at USD 5.17 Billion in 2024 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 6.79% through 2030. This
can be due to collaborations and partnerships among leading companies with a
diverse approach to merge the expertise of individual companies and to
strengthen their position in the market.
Antibiotic stewardship programs play a crucial
role in shaping the demand for peptide antibiotics and antibiotics in general.
These programs are implemented in healthcare settings to promote responsible
and judicious use of antibiotics. While antibiotic stewardship programs are
primarily aimed at optimizing antibiotic use and curbing the rise of antibiotic
resistance, they can indirectly influence the demand for specific types of
antibiotics like peptide antibiotics. Antibiotic stewardship programs emphasize the importance of selecting the most appropriate antibiotic for a given infection. Peptide antibiotics, with their specific mechanisms of action and limited spectrum of activity, can be valuable in achieving targeted therapy. When
stewardship programs recommend or require the use of specific antibiotics based
on microbial susceptibility testing, peptide antibiotics may be chosen if they
are effective against the identified pathogen. One key objective of antibiotic
stewardship is to reduce the unnecessary use of broad-spectrum antibiotics,
which can contribute to antibiotic resistance. Peptide antibiotics, often
having a narrower spectrum of activity, can be preferred in cases where a more
targeted approach is appropriate.
Peptide
antibiotics are anti-infective and anti-tumor medications that contain
polypeptide chains. The two types of peptide antibiotics are those produced by
ribosomal synthesis and those produced by non-ribosomal synthesis. The benefits
of peptide antibiotics include their high specificity, high efficacy, and low
toxicity.
In
September 2021, to produce Daptomycin for injection to treat severe bacterial
infections, such as skin and soft tissue infections, bloodstream infections,
and endocarditis, AuroMedics Pharma LLC stated that it has gained permission
from the USFDA. Under the trade name Cubicin, daptomycin is a lipopeptide antibiotic
that is given intravenously. It displaces the bacterial cell membrane to
function. Gramicidin, which is often created in conjunction with other
antibiotics, shares a similar mechanism. With the caveat that oral use of this
medication may be harmful, it is an antibacterial agent for the topical
treatment of skin infections. This medication has a significant deal of
potential as a treatment for renal cell carcinoma, the most frequent kind of
kidney cancer in people, according to in vitro and in vivo research.
Patient adherence is a significant challenge
in the global peptide antibiotics market, as it is in healthcare more broadly.
Patient adherence refers to a patient's ability and willingness to follow
prescribed treatment plans, including taking medications as directed by
healthcare providers. Some peptide antibiotics may have complex dosing
regimens, requiring patients to take multiple doses at specific times or with
certain conditions (e.g., with or without food). These complexities can lead to
confusion and non-adherence. The frequency of administration can vary among
peptide antibiotics. Some may require multiple daily doses, while others are
administered less frequently. Frequent dosing can be burdensome for patients,
leading to missed doses. The duration of treatment with peptide antibiotics can
vary depending on the type and severity of the infection. Longer treatment
courses may increase the likelihood of non-adherence, as patients may
discontinue treatment prematurely.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on "Peptide Antibiotics Market”
Global Peptide Antibiotics Market segmentation is
based on
Type, Route of Administration, Distribution
Channel, Region and Company.
Based on Route of Administration, The injectable category is witnessing the fastest growth in the Peptide Antibiotics Market due to several key factors. Injectable peptide antibiotics offer higher bioavailability, ensuring efficient drug delivery and rapid therapeutic action. This is particularly crucial in treating severe infections, where immediate response is necessary. Moreover, the increasing prevalence of multidrug-resistant (MDR) bacterial infections has heightened the demand for advanced treatment options, with injectable peptide antibiotics emerging as a preferred choice due to their potency and precision. Healthcare professionals often favor injectables for critical care settings, such as hospitals and intensive care units, where patients require immediate and controlled antibiotic administration. Additionally, ongoing advancements in formulation technologies, such as liposomal and nanoparticle-based drug delivery systems, are further enhancing the stability and effectiveness of injectable peptide antibiotics. Rising investments in research and development (R&D) for novel peptide-based therapeutics and the growing focus on addressing antibiotic resistance are also key drivers propelling this segment's growth.
Based on Region, Asia-pacific region to fastest growth in
the Global Peptide Antibiotics Market. Many countries in the Asia-Pacific
region have been increasing their healthcare expenditure to improve healthcare
infrastructure and access to medical services. This includes investments in
research and development, which can boost the development and adoption of
peptide antibiotics. The Asia-Pacific region is home to a significant and
rapidly aging population. Older adults are more susceptible to infections,
driving the demand for antibiotics, including peptide antibiotics, to treat
age-related health issues and infections. Several emerging economies in Asia,
such as China and India, have been experiencing robust economic growth. This
growth has led to increased healthcare spending, improved healthcare access,
and greater demand for advanced medical treatments.
Some
of the major companies operating in the Global
Peptide Antibiotics Market include:
- Pfizer
Inc.
- Merck
& Co., Inc.
- AbbVie
Inc
- GSK Plc
- Sandoz
International GmbH
- Novartis
AG
- Xellia
Pharmaceuticals
- The Menarini Group
- Teva Pharmaceutical Industries Ltd.
- AuroMedics Pharma LLC
Download Free Sample Report
Customers can also request
10% free customization on this report
“The Global Peptide Antibiotics Market is poised for significant growth, driven by increasing demand for effective treatments against multidrug-resistant infections. The expanding competitive landscape, coupled with the presence of key industry players dedicated to advancing antibiotic research and innovation, is expected to fuel market expansion in the coming years. Additionally, rising investments in R&D and technological advancements in peptide drug formulations will further enhance the market’s potential,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based global management consulting firm.
"Peptide
Antibiotics Market – Global Industry Size, Share, Trends, Opportunity, and
Forecast, Segmented by
Type (Non-Ribosomal Synthesized
Peptide Antibiotics, Ribosomal Synthesized Peptide Antibiotics), by Route of
Administration (Injectable, Oral, Topical), by Distribution Channel (Hospital
Pharmacy, Online Pharmacy & Retail Pharmacy), By Region and Competition, 2020-2030F," evaluated
the future growth potential of Global Peptide Antibiotics Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide innovative market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Peptide Antibiotics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com